| Literature DB >> 17251015 |
Susan L Mercer1, Hazem E Hassan, Christopher W Cunningham, Natalie D Eddington, Andrew Coop.
Abstract
P-Glycoprotein (P-gp) is an efflux transporter which is up-regulated at the blood-brain barrier in both morphine- and oxycodone-tolerant rats. Numerous studies have shown that many clinically employed opioid analgesics are substrates for P-gp, suggesting that up-regulation of P-gp may contribute to the development of central tolerance to opioids. The studies herein focus on the development of SAR for P-gp substrate activity in the meperidine series of compounds, and show that a meperidine analog of greater potency, N-phenylbutyl-N-normeperidine, has low activity as a P-gp substrate and has the potential to be utilized as a tool to study the contribution of P-gp to the development of central tolerance to opioids.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17251015 PMCID: PMC1850229 DOI: 10.1016/j.bmcl.2006.12.042
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823